XSTAT Spiral Development

The U.S. Army Contracting Command - Aberdeen Proving Ground (ACC-APG), Natick Contracting Division (NCD) in support of the Program Manager - Survival, Support and Equipment Systems (PM-SSES) intends to award a firm fixed price research and development contract on a sole source basis to RevMedX, located at 2599 SW Canyon Creek RD STE C, Wilsonville, OR 97070-9677, under the authority as prescribed in 10 USC 2304(c)(1) and FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The requirement is to conduct research and development on the XSTAT hemostatic devices in order to explore the effect of proposed changes to the design of the XSTAT Applicator and Hemostatic Sponges on performance of XSTAT in the treatment of non-compressible hemorrhagic injuries and on the cost of the applicator. The XSTAT family of products are proprietary to RevMedX, and no other source is capable of performing the design changes and research on XSTAT necessary to meet the agency's requirements.

The North American Industry Classification System (NAICS) for this requirement is 541711 and the size standard is 500 employees.

THIS IS NOT A REQUEST FOR PROPOSALS. No solicitation document is available.

Interested parties may identify their interest and capability by sending responses to this requirement to the Army Contracting Command - Aberdeen Proving Ground CCAP-SCN, Natick Contracting Division via e-mail ONLY to paul.d.yatsco.civ@mail.mil AND jean.t.greenwood.civ@mail.mil, no later than 4:00 p.m. EST 1 June 2015. The U.S. Government will not pay for any information or administrative cost incurred in response to this Notice. All costs associated with responding to this Notice will be solely at the expense of the interested party.